A leading provider of dialysis care in the United States has acquired Mt. Baker Kidney Center for an undisclosed amount of money.
The sale to DaVita Kidney Care was announced late in the day Wednesday, June 1. Mt. Baker’s 46 clinical and non-clinical employees will remain.
The center opened in Bellingham in 1980. Its representatives said patients shouldn’t expect immediate changes.
“Patient care continues as usual. All employees have been offered positions by DaVita,” said Debbie Ahl, interim executive director for Mt. Baker Kidney Center.
Ahl added that patients likely will “see no change in their normal routine, same amazing caregivers, same medical director (Dr. Bill Lombard). Over time, DaVita will be able to bring more to the patients than a small community center can offer.”
The center is at 410 Birchwood Ave., Suite 100. It is being renamed Davita/Mt. Baker Kidney Center.
The sale occurred after more than two years of research, according to Mt. Baker.
Saying the center was “operating in an increasingly complex world,” board president Julie Johansen said Mt. Baker decided to sell to DaVita because of the company’s excellence in patient care, innovation in this area of medicine, business expertise and reputation for clinical leadership.
DaVita Kidney Care operates or provides administrative services at 2,278 outpatient dialysis centers in the U.S. that serve about 180,000 patients.
The company also operates 124 outpatient dialysis centers in 10 countries outside the U.S.
The acquisition will allow Mt. Baker to continue what it does well and offer more in the future, according to Lombard.
“This will allow the center, a Medicare five-star rated unit, to continue to provide the highest quality of dialysis care for which it is noted, and retain its incredibly competent and compassionate staff so well known to our patients,” he said in a news release.
DaVita will be able to provide services and programs for patients that a smaller, independent unit like Mt. Baker would never be able to provide, Lombard added.